ID Q0PHL7_9RALS Unreviewed; 354 AA.
AC Q0PHL7;
DT 05-SEP-2006, integrated into UniProtKB/TrEMBL.
DT 05-SEP-2006, sequence version 1.
DT 27-MAR-2024, entry version 73.
DE SubName: Full=BtxF {ECO:0000313|EMBL:ABG82171.1};
GN Name=btxF {ECO:0000313|EMBL:ABG82171.1};
OS Ralstonia sp. PHS1.
OC Bacteria; Pseudomonadota; Betaproteobacteria; Burkholderiales;
OC Burkholderiaceae; Ralstonia.
OX NCBI_TaxID=119276 {ECO:0000313|EMBL:ABG82171.1};
RN [1] {ECO:0000313|EMBL:ABG82171.1}
RP NUCLEOTIDE SEQUENCE.
RC STRAIN=PHS1 {ECO:0000313|EMBL:ABG82171.1};
RA Lee S.K., Lee S.B.;
RT "Nucleotide sequence and functional analysis of the btx operon for
RT catabolism of BTEX compounds in Ralstonia sp. strain PHS1.";
RL Submitted (JUN-2006) to the EMBL/GenBank/DDBJ databases.
CC -!- COFACTOR:
CC Name=FAD; Xref=ChEBI:CHEBI:57692;
CC Evidence={ECO:0000256|ARBA:ARBA00001974};
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; DQ834383; ABG82171.1; -; Genomic_DNA.
DR AlphaFoldDB; Q0PHL7; -.
DR GO; GO:0051537; F:2 iron, 2 sulfur cluster binding; IEA:UniProtKB-KW.
DR GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR GO; GO:0016491; F:oxidoreductase activity; IEA:InterPro.
DR CDD; cd00207; fer2; 1.
DR Gene3D; 3.10.20.30; -; 1.
DR Gene3D; 3.40.50.80; Nucleotide-binding domain of ferredoxin-NADP reductase (FNR) module; 1.
DR Gene3D; 2.40.30.10; Translation factors; 1.
DR InterPro; IPR036010; 2Fe-2S_ferredoxin-like_sf.
DR InterPro; IPR001041; 2Fe-2S_ferredoxin-type.
DR InterPro; IPR006058; 2Fe2S_fd_BS.
DR InterPro; IPR012675; Beta-grasp_dom_sf.
DR InterPro; IPR008333; Cbr1-like_FAD-bd_dom.
DR InterPro; IPR017927; FAD-bd_FR_type.
DR InterPro; IPR039261; FNR_nucleotide-bd.
DR InterPro; IPR001433; OxRdtase_FAD/NAD-bd.
DR InterPro; IPR017938; Riboflavin_synthase-like_b-brl.
DR PANTHER; PTHR47354; NADH OXIDOREDUCTASE HCR; 1.
DR PANTHER; PTHR47354:SF5; PROTEIN RFBI; 1.
DR Pfam; PF00970; FAD_binding_6; 1.
DR Pfam; PF00111; Fer2; 1.
DR Pfam; PF00175; NAD_binding_1; 1.
DR PRINTS; PR00410; PHEHYDRXLASE.
DR SUPFAM; SSF54292; 2Fe-2S ferredoxin-like; 1.
DR SUPFAM; SSF52343; Ferredoxin reductase-like, C-terminal NADP-linked domain; 1.
DR SUPFAM; SSF63380; Riboflavin synthase domain-like; 1.
DR PROSITE; PS00197; 2FE2S_FER_1; 1.
DR PROSITE; PS51085; 2FE2S_FER_2; 1.
DR PROSITE; PS51384; FAD_FR; 1.
PE 4: Predicted;
KW 2Fe-2S {ECO:0000256|ARBA:ARBA00022714};
KW Iron {ECO:0000256|ARBA:ARBA00023004};
KW Iron-sulfur {ECO:0000256|ARBA:ARBA00023014};
KW Metal-binding {ECO:0000256|ARBA:ARBA00022714}.
FT DOMAIN 3..93
FT /note="2Fe-2S ferredoxin-type"
FT /evidence="ECO:0000259|PROSITE:PS51085"
FT DOMAIN 102..204
FT /note="FAD-binding FR-type"
FT /evidence="ECO:0000259|PROSITE:PS51384"
SQ SEQUENCE 354 AA; 39161 MW; 8F45AB35BA8A46FF CRC64;
MTYQLNIQPL GATIEVEEGQ TILDAALRQG IYIPHACGHG LCGTCKVQVC DGEVDLGDAN
PFALMDFERE ERKALACCAT LLDDTTIEAD IEEDPDAEVI PVEDFNAEVT RIEQLTPTIK
AVFLRLDQPI HFQAGQYVQL EIPELRQTRA FSIANSPADV AATGEIELNI RRVPGGQGTG
YIHEQLAVGN ILHVTGPYGR FFVRRSADQP MVFMAGGSGL SSPRSMIIDL LQSGWSRPIT
LVYGQRNEAE LYYDEEFREL SQRYSNFSYV PALSEKAEGA THPLAQGFVH EVAKAHFGNN
FSGHKAYLCG PPAMIDACVT TLIQGRLFER DIYFEKFISA ADAQQVRSPL FKRV
//
